| 前收市價 | 66.94 |
| 開市 | 67.58 |
| 買盤 | 63.40 |
| 賣出價 | 66.75 |
| 拍板 | 880.00 |
| 到期日 | 2024-10-18 |
| 今日波幅 | 64.85 - 67.58 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 230 |
Barrons.comEli Lilly’s Weight-Loss Franchise Has Been a Massive Winner Under Dave Ricks
Zepbound and related products could generate more than $50 billion of sales in 2029. There is a lot more in Lilly’s pipeline.
ZacksHere's How Much a $1000 Investment in Eli Lilly Made 10 Years Ago Would Be Worth Today
Holding on to popular or trending stocks for the long-term can make your portfolio a winner.
ZacksThe Zacks Analyst Blog Highlights Pfizer, Johnson & Johnson and Eli Lilly
Pfizer, Johnson & Johnson and Eli Lilly are part of the Zacks top Analyst Blog.
